Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients

Acta Diabetologica

Volumn 44, Issue 4, 2007, Pages 193-200

  Ahmad Khan, Haseeb ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Biomarker; Dyslipidemia; Glycemic control; HbA1c; Serum lipids; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; LIPOPROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DIABETES CONTROL; DIABETIC PATIENT; DIAGNOSTIC VALUE; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; METABOLISM; RETROSPECTIVE STUDY; SAUDI ARABIA; SEXUAL DEVELOPMENT; SOLDIER;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MILITARY PERSONNEL; RETROSPECTIVE STUDIES; SAUDI ARABIA; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 36248943645     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0003-x     Document Type: Article

References (50)

1. Berry C, Tardif JC, Bourassa MG (2007) Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol 49:631-642
2. Sultan A, Thuan JF, Avignon A (2006) Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions? Diabetes Metab 32:559-567
3. Rader DJ (2007) Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120:S12-S18
4. Giansanti R, Rabini RA, Romagnoli F, Fumelli D, Sorichetti P, Boemi M, Fumelli P (1999) Coronary heart disease, type 2 diabetes mellitus and cardiovascular disease risk factors: a study on a middle-aged and elderly population. Arch Genontol Geriatr 29:175-182
5. Jones PH (2006) Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus. Am J Cardiol 99:133-140
6. Smith SC Jr (2007) Multiple risk factors for cardiovascular disease and diabetes mellitus. Am J Med 120:S3-S11
7. Nasri H, Yazdani M (2006) The relationship between serum LDL-cholesterol, HDL-cholesterol and systolic blood pressure in patients with type 2 diabetes. Kardiol Pol 64:1364-1368
8. Gotto AM Jr (2007) Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus. Am J Cardiol 99:3-5
9. Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA (2004) A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 53:2883-2892
10. Davey RA, Tabbutt NC, Favaloro JM, O'Neal DN, Rae D, Zajac JD, Best JD (2006) Severe combined hyperlipidemia and retinal lipid infiltration in a patient with type 2 diabetes mellitus. Lipids Health Dis 5:29-33
11. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE (2002) Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications trial. Diabetes Care 25:275-278
12. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW (2005) Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 165:1910-1916
13. Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett AR (2005) Glycemia (haemoglobin A1c) and incident of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Lancet Neurol 4:821-826
14. Ravipati G, Aronow WS, Ahn C, Sujata K, Saulle LN, Weiss MB (2006) Association of hemoglobin A1c level with the severity of coronary artery disease in patients with diabetes mellitus. Am J Cardiol 97:968-969
15. Selvin E, Wattanakit K, Steffens MW, Coresh J, Sharrett AR (2006) HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 29:877-882
16. Kawasumi M, Tanaka Y, Uchino H, Shimizu T, Tamura Y, Sato F, Mita T, Watada H, Sakai K, Hirose T, Kawamori R (2006) Strict glycemic control ameliorates the increase of carotid IMT in patients with type 2 diabetes. Endocr J 53:45-50
17. Woodward A, Wallymahmed M, Wilding J, Gill G (2005) Improved glycemic control: an unintended benefit of a nurse-led cardiovascular risk reduction clinic. Diabet Med 22:1272-1274
18. Nakamura K, Yamagishi SI, Adachi H, Kurita-Nakamura Y, Matsui T, Yoshida T, Sato A, Imaizumi T (2007) Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease. Diabetes Metab Res Rev 23(5):368-371
19. Rosediani M, Azidah AK, Mafauzy M (2006) Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine. Med J Malaysia 61:67-71
20. Akbar DH, Ahmed MM, Algamdi AA (2003) Cardiovascular risk factor in Saudi Arabian and non-Saudi Arabian diabetic patients in Saudi Arabia. East Medit Health J 9:884-892
21. Ciardullo AV, Azzolini L, Bevini M, Cadioli T, Malavasi P, Morellini A et al (2004) Non-HDL cholesterol predicts coronary heart disease in primary prevention: findings from an Italian 40-69-year-old cohort in general practice. Monaldi Arch Chest Dis 62:69-72
22. Ito C, Maeda R, Ishida S, Sasaki H, Harada H (2000) Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract 50:225-230
23. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, Li JK, So WY, Chan WB, Cockram CS (1998) Glycated hemoglobin and cardiovascular risk factors in Chinese subjects with normal glucose tolerance. Diabet Med 15:573-578
24. Ladeia AM, Adan L, Couto-Silva AC, Hiltner A, Guimaraes AC (2006) Lipid profile correlates with glycemic control in young patients with type 1 diabetes mellitus. Prev Cardiol 9:82-88
25. Faulkner MS, Chao WH, Kamth SK, Quinn L, Fritschi C, Maggiore JA, Williams RH, Reynolds RD (2006) Total homocysteine, diet and lipid profiles in type 1 and type 2 diabetic and non-diabetic adolescents. J Cardiovasc Nurs 21:47-55
26. Chan WB, Tong PC, Chow CC, So WY, Ng MC, Ma RC, Osaki R, Cockram CS, Chan JC (2005) Triglyceride predicts cardiovascular mortality and its relationship with glycemia and obesity in Chinese type 2 diabetic patients. Diabetes Metab Res Rev 21:183-188
27. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234
28. Gu K, Cowie CC, Harris MI (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291-1297
29. Walden C, Knopp R, Wahl P, Beach K, Strandness E (1984) Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 311:953-959
30. Howard B, Cowan L, Go O, Welty T, Robbins D, Lee E (1998) Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the Strong Heart Study. Diabetes Care 21:1258-1265
31. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, Baron AD (2000) Type II diabetes abrogates sex differences in endothelial function in pre-menopausal women. Circulation 101:2040-2046
32. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E (2005) Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 28:514-520
33. The Diabetes Prevention Program Research Group (2005) Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program. Diabetes Care 28:2472-2479
34. Mohamad M, Arshad F, Noor MIM, Ali R (1997) Prevalence of dyslipidemia in non-insulin-dependent diabetic patients attending armed forces clinics in Kuala Lumpur. Asia Pacific J Clin Nutr 6:203-206
35. Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H (2006) Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovasc Diabetol 5:15
36. Sibley SD, Thomas W, de Boer I, Brunzell JD, Steffes MW (2006) Gender and elevated albumin excretion in the Diabetes Control and Complications trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity. Am J Kidney Dis 47:223-232
37. Doruk H, Mas MR, Ateskan U, Isik AT, Saglam M, Kutlu M (2005) The relationship between age ad carotid artery intima-media thickness, hemoglobin A1c in nondiabetic, healthy geriatric population. Arch Gerontol Geriatr 41:113-119
38. Kalofoutis C, Piperi C, Zisaki A, Singh J, Harris F, Phoenix D, Alaveras A, Kalofoutis A (2006) Differences in expression of cardiovascular risk factors among type 2 diabetes mellitus patients of different age. Ann N Y Acad Sci 1084:166-177
39. Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK et al (2007) Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med 161:159-165
40. El-Hazmi MA, Al-Swailem AR, Warsy AS, Al-Meshari AA, Sulaimani R, Al-Swailem AM, Magbool GM (1999) Lipids and related parameters in Saudi type II diabetes mellitus patients. Ann Saudi Med 19:304-307
41. Daghash MH, Bener A, Zirie M, Dabdoub W, Al-Hamaq AO, Al-Arabi ZA (2007) Lipoprotein profile in Arabian type 2 diabetic patients: relationship to coronary artery diseases. Int J Cardiol (in press)
42. Lin SD, Tu ST, Hsu SR, Lin KC, Sheu WH (2006) Characteristics predicting dyslipidemia in drug-naive type 2 diabetes patients. J Chin Med Assoc 69:404-408
43. Smellie WS (2006) Hypertriglyceridaemia in diabetes. BMJ 333:1257-1260
44. DeFaria Yeh D, Freeman MW, Meigs JB, Grant RW (2007) Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol. Am J Cardiol 99:1-4
45. Sun YH, Yang YJ, Pei WD, Wu YJ, Gao RL (2006) Patients with low high-density lipoprotein-cholesterol or smoking are more likely to develop myocardial infarction among subjects with a visible lesion or stenosis in coronary artery. Circ J 70:1602-1605
46. Bellomo A, Mancinella M, Troisi G, Ettorre E, Marigliano V (2007) Diabetes and metabolic syndrome (MS). Arch Gerontol Geriatr 44:61-67
47. Avogaro A, Giorda C, Maggini M, Mannucci E, Raschetti R, Lombardo F et al (2007) Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment and geographic location. Diabetes Care 30(5):1241-1247
48. Eshaghian S, Horwich TB, Fonarow GC (2006) An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J 151:91
49. Schulze MB, Shai I, Manson JE, Li T, Rifai N, Jiang R, Hu FB (2004) Joint role of non-HDL cholesterol and glycated haemoglobin in predcting future coronary heart disease events among women with type 2 diabetes. Diabetologia 47:2129-2136
50. Onat A, Sari I, Yazici M, Can G, Hergenc G, Avci GS (2006) Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome. Int J Cardiol 108:89-95